Microdose would like to sincerely thank all of our notable event partners and sponsors who helped make our Psychedelic Capital events a success. With their incredible support, we cover the top companies, latest IPOs, newest opportunities & deepest insights in the emerging psychedelic space. Along with helping put on a dynamic event, our partners help drive progress forward for the entire psychedelic community. The team at Microdose is grateful for the opportunity to innovatively collaborate with such dynamic players in the industry. In this piece, we would like to give special thanks to our sponsors and partners that help make Psychedelic Capital possible:

@fieldtriphealth – We’re thrilled to collaborate with Field Trip Health, an innovative organization offering evidence-based, legal psychedelic therapies to help the world heal from depression.

PsyCap Recap: 3 Key Takeaways from the Field Trip Health Presentation at Psychedelic Capital

@HavnLife – We would also like to thank Havn Life, a unique organization specializing in the standardization, extraction and formulation of psychedelic compounds for scientific research and natural health care products for human performance.

PsyCap Recap: 3 Key Takeaways From the HAVN Life Presentation at Psychedelic Capital

@PureExtracts_CA – We want to recognize Pure Extracts, a CO2 extraction specialist with a focus on strategic distribution and product innovation in plant based compounds. 

PsyCap Recap: 3 Key Takeaways From the Pure Extracts Corp. Presentation at Psychedelic Capital


@MindsetPharma – We’d like to give a shout out to Mindset Pharma, a psychedelic-based drug discovery business creating novel, patent-pending psychedelic compounds for treatment-resistant neurological and psychiatric disorders.

PsyCap Recap: 3 Key Takeaways From the Mindset Pharma Presentation at Psychedelic Capital

#fivepharmaceuticals – We’d like to acknowledge FIVE Pharmaceuticals and their mission to be the first to market publicly traded Canadian pharmaceutical Psilocybin Company specializing in mental health treatment for first responders and veterans. They aim to target conditions such as PTSD, depression, drug addictions and other mental health disorders through Health Canada licensing with Good Manufacturing Practices (GMP) and ISO 9001 standards.

#Ehave – We are pleased to highlight our partner Ehave, a data-driven ecosystem for the digital assessment and remediation of the most common mental health disorders faced by children, adolescents, and adults.

PsyCap Recap: 3 Key Takeaways from the EHave, Inc. Presentation at Psychedelic Capital

@MagicMedInd, We’d like to thank our partners at MagicMed Industries, an innovative team that intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products. 


PsyCap Recap: 3 Key Takeaways from MagicMed Industries’ Presentation at Psychedelic Capital

#Aion Therapeutics – We’d like to thank Dr. Stephen Barnhill and his team at Aion Therapeutic Inc. for their use of novel AI techniques to isolate and combine the most important healing compounds in medicinal mushrooms and cannabis to create radically effective new disease treatments. 


PsyCap Recap: 3 Key Takeaways from Aion Therapeutics Inc.’s Psychedelic Capital Presentation 

#Wake Network – We’d like to thank the up-and-coming startup, The Wake Network, for furthering the research of psychedelic medicine with the help of mycology and fungus-derived therapy for patients fighting mental illnesses. Their primary focus is on treating conditions like PTSD, depression, alcoholism, and addictions to opioids to name a few.

#Cybin Corp – We’d like to thank our sponsor, Cybin Corp, an innovative bio-pharma company developing mushroom-derived pharmaceuticals for mental illness. They are also developing health products from mushrooms that support areas like cognition and immune response. Their groundbreaking sublingual psilocybin development program is poised to be one of the first commercially approved psychedelic medications for mental health.

#NewWaveHoldings – We’d like to give a shout out to our partner New Wave Holdings Corp, an investment issuer focused on the burgeoning psychedelic and esports sectors. 

#Bexson Biomedical – We’d like to thank our sponsor, Bexson Biomedical, a unique biotech firm is developing a novel formulations of ketamine for chronic and acute pain disorders. With the opioid epidemic becoming a public health crisis, the need for new, non-opioid based pain management therapeutics is greater now than ever before. We support the important work Bexson is doing and are grateful for their support.  

Huge thanks to all of our sponsors that helped make our Psychedelic Capital events so dynamic, informative and engaging! To check out more of our incredible sponsors, check out the “Sponsors” page on the Microdose website. If you are interested in learning about sponsorship opportunities for Psychedelic Capital, reach out to patrick@microdose.buzz for details. See you at our next PsyCap event on October 29th